The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemical and biological evolution of a nucleotide-binding protein
Rossmann, M. G., Moras, D., & Olsen, K. W. (1974) · Nature · doi:10.1038/250194a0 · Cited by 1,469
Activation of molecular oxygen by flavins and flavoproteins.
Massey, V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31664-2 · Cited by 816
GeneCards: integrating information about genes, proteins and diseases
Rebhan, M. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01103-7 · Cited by 773
Enzymatic Basis of Detoxication
(1980) · Elsevier eBooks · doi:10.1016/c2012-0-01570-0 · Cited by 693
Interaction of pyrophosphate moieties with .alpha.-helixes in dinucleotide-binding proteins
Wierenga, R. K., De Maeyer, M. C. H., & Hol, W. G. J. (1985) · Biochemistry · doi:10.1021/bi00327a012 · Cited by 469
Lipoic Acid as a Potential Therapy for Chronic Diseases Associated with Oxidative Stress
Smith, A. R., Shenvi, S. V., Widlansky, M., Suh, J. H., & Hagen, T. M. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365387 · Cited by 461
PRINTS and its automatic supplement, prePRINTS
Attwood, T. K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg030 · Cited by 388
The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative Enzymes
Hines, R. N., & McCarver, D. G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.355 · Cited by 365
Flavin-containing monooxygenases: Catalytic mechanism and substrate specificities
Ziegler, D. M. (1988) · Drug Metabolism Reviews · doi:10.3109/03602538809049617 · Cited by 351
α-Lipoic Acid in Liver Metabolism and Disease
Bustamante, J. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00371-7 · Cited by 349
The FSSP database of structurally aligned protein fold families.
Holm, L., & Sander, C. (1994) · Europe PMC (PubMed Central) · Cited by 315
Lang, D., Yeung, C., Peter, R., Ibarra, C., Gasser, R., Itagaki, K., Philpot, R., & Rettie, A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00218-4 · Cited by 303
Crystal structure of a Baeyer–Villiger monooxygenase
Malito, E., Alfieri, A., Fraaije, M. W., & Mattevi, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404538101 · Cited by 296
Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome
Dolphin, C. T., Janmohamed, A., Smith, R. L., Shephard, E. A., & Phillips, L. R. (1997) · Nature Genetics · doi:10.1038/ng1297-491 · Cited by 284
Ziegler, D. M., & Mitchell, C. H. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90017-3 · Cited by 258
Three-dimensional structure of glutathione reductase at 2 Å resolution
Thieme, R., Pai, E. F., Schirmer, R. H., & Schulz, G. E. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90126-1 · Cited by 256
Recent Studies on the Structure and Function of Multisubstrate Flavin-Containing Monooxygenases
Ziegler, D. M. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001143 · Cited by 248
Drug Metabolism and Drug Toxicity
Ames, M. M. (1985) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60310-3 · Cited by 246
Human Hepatic Flavin-Containing Monooxygenases 1 (FMO1) and 3 (FMO3) Developmental Expression
Koukouritaki, S. B., Simpson, P., Yeung, C. K., Rettie, A. E., & Hines, R. N. (2002) · Pediatric Research · doi:10.1203/00006450-200202000-00018 · Cited by 245
ZIEGLER, D. M. (1980) · Enzymatic Basis of Detoxication · doi:10.1016/b978-0-12-380001-5.50015-3 · Cited by 235
The Antituberculosis Drug Ethionamide Is Activated by a Flavoprotein Monooxygenase
Vannelli, T. A., Dykman, A., & Ortiz de Montellano, P. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110751200 · Cited by 232
Treacy, E. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.839 · Cited by 228
Identification of a Baeyer–Villiger monooxygenase sequence motif
Fraaije, M. W., Kamerbeek, N. M., van Berkel, W. J. H., & Janssen, D. B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02623-6 · Cited by 225
Structural and Catalytic Properties of the Mammalian Flavin-Containing Monooxygenase
Cashman, J. R. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00044a001 · Cited by 224
AN OVERVIEW OF THE MECHANISM, SUBSTRATE SPECIFICITIES, AND STRUCTURE OF FMO s
Ziegler, D. M. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120005650 · Cited by 216
The liver microsomal FAD-containing monooxygenase. Spectral characterization and kinetic studies.
Poulsen, L. L., & Ziegler, D. M. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50388-4 · Cited by 212
Cashman, J. R., Park, S. B., Yang, Z. C., Wrighton, S. A., Jacob, P., & Benowitz, N. L. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00029a008 · Cited by 211
Trimethylaminuria: the fish malodor syndrome.
Mitchell, S. C., & Smith, R. L. (2001) · PubMed · Cited by 209
Lawton, M. P., Cashman, J. R., Cresteil, T., Dolphin, C. T., Elfarra, A. A., Hines, R. N., Hodgson, E., Kimura, T., Ozols, J., Phillips, I. R., et al. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1035 · Cited by 204
Self-citationThioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system.
Hunter, A. L., Holscher, M. A., & Neal, R. A. (1977) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30789-5 · Cited by 194
Gene expression profiling of oxidative stress on atrial fibrillation in humans
Kim, Y. H., Lee, J. H., Lim, D. S., Shim, W. J., Ro, Y. M., Park, G. H., Becker, K. G., Cho-Chung, Y. S., & Kim, M.-K. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.45 · Cited by 174
Hernandez, D., Janmohamed, A., Chandan, P., Phillips, I. R., & Shephard, E. A. (2004) · Pharmacogenetics · doi:10.1097/00008571-200402000-00006 · Cited by 173
MPTP: A neurotoxin producing a parkinsonian syndrome
Crossman, A. R. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90228-4 · Cited by 169
Hagen, T. M., Moreau, R. F., Suh, J. H., & Visioli, F. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02119.x · Cited by 168
The molecular biology of the flavin-containing monooxygenases of man
Phillips, I. R., Dolphin, C. T., Clair, P., Hadley, M. R., Hutt, A. J., McCombie, R. R., Smith, R. L., & Shephard, E. A. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03580-2 · Cited by 149
Rawden, H. C., Kokwaro, G. O., Ward, S. A., &, & Edwards, G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00170.x · Cited by 146
TEALE, F. W. J. (1977) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(77)90259-6 · Cited by 144
Dolphin, C. T., Beckett, D. J., Janmohamed, A., Cullingford, T. E., Smith, R. L., Shephard, E. A., & Phillips, I. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30599 · Cited by 142
Immunoquantitation of FMO1 in Human Liver, Kidney, and Intestine
Yeung, C. K., Lang, D. H., Thummel, K. E., & Rettie, A. E. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15194-x · Cited by 132
Hines, R. N., Cashman, J. R., Philpot, R. M., Williams, D. E., & Ziegler, D. M. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1042 · Cited by 127
Self-citationStörmer, E., Roots, I., & Brockmöller, J. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00296.x · Cited by 124
Mild trimethylaminuria caused by common variants in FM03 gene
Zschocke, J., Kohlmueller, D., Quak, E., Meißner, T., Hoffmann, G. F., & Mayatepek, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)80019-1 · Cited by 121
IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES
Wynalda, M. A., Hutzler, J. M., Koets, M. D., Podoll, T., & Wienkers, L. C. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.878 · Cited by 114
Mechanism of inactivation of thyroid peroxidase by thioureylene drugs
Engler, H., Taurog, A., & Nakashima, T. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90296-9 · Cited by 112
Cashman, J., Camp, K., Fakharzadeh, S., Fennessey, P., Hines, R., Mamer, O., Mitchell, S., Preti, G., Schlenk, D., & Smith, R. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489505 · Cited by 110
Cashman, J. R., & Zhang, J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.10.1043 · Cited by 110
New sequence motifs in flavoproteins: Evidence for common ancestry and tools to predict structure
Vallon, O. (2000) · Proteins Structure Function and Bioinformatics · Cited by 108
Rauckman, E. J., Rosen, G. M., & Kitchell, B. B. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11537-x · Cited by 106
Trimethylaminuria and a humanFMO3 mutation database
Hernandez, D., Addou, S., Lee, D., Orengo, C. A., Shephard, E. A., & Phillips, I. R. (2003) · Human Mutation · doi:10.1002/humu.10252 · Cited by 105
Multisubstrate flavin-containing monooxygenases: applications of mechanism to specificity
Poulsen, L. L., & Ziegler, D. M. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03583-t · Cited by 101
Lawton, M. P., Gasser, R. B., Tynes, R. E., Hodgson, E., & Philpot, R. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39441-4 · Cited by 101
Frederick, C. B., Mays, J. B., Ziegler, D. M., Guengerich, F. P., & Kadlubar, F. F. (1982) · PubMed · Cited by 100
Mushiroda, T., Douya, R., Takahara, E., & Nagata, O. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12055-x · Cited by 98
Hajjar, N. P., & Hodgson, E. (1980) · Science · doi:10.1126/science.7403873 · Cited by 96
Usmani, K. A., Karoly, E. D., Hodgson, E., & Rose, R. L. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.333 · Cited by 96
Hines, R. N., Hopp, K. A., Franco, J., Saeian, K., & Begun, F. P. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.320 · Cited by 95
Moroni, P., Buronfosse, T., Longin‐Sauvageon, C., Delatour, P., & Benoǐt, E. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06513-4 · Cited by 95
Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases
Hamman, M. A., HAEHNERDANIELS, B., Wrighton, S. A., Rettie, A. E., & Hall, S. D. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00301-4 · Cited by 94
Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans
Ford, J. G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.11.1971 · Cited by 89
MPTP, a neurotoxin producing a Parkinsonian syndrome
Markey, S. P. (1986) · Academic Press eBooks · Cited by 88
N-Deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes
Rodríguez, R. L., & Acosta, D. (1997) · Toxicology · doi:10.1016/s0300-483x(96)03560-3 · Cited by 88
Mechanisms for the Cytotoxicity of Cysteamine
Jeitner, T. M. (2001) · Toxicological Sciences · doi:10.1093/toxsci/63.1.57 · Cited by 88
Park, S. B., Jacob, P., Benowitz, N. L., & Cashman, J. R. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00036a019 · Cited by 87
Whetstine, J. R., Yueh, M., Hopp, K. A., McCarver, D. G., Williams, D. E., Park, C., Kang, J., Cha, Y.-N., Dolphin, C. T., Shephard, E. A., et al. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9050 · Cited by 86
Self-citationChemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
Cashman, J. R., PARK, S. B., Yang, Z., Washington, C. B., Gomez, D. Y., Giacomini, K. M., & Brett, C. M. A. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07460-4 · Cited by 83
Overby, L. H., Buckpitt, A. R., Lawton, M. P., Atta-Asafo-Adjei, E., Schulze, J., & Philpot, R. M. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1163 · Cited by 82
Suh, J.-K., Poulsen, L. L., Ziegler, D. M., & Robertus, J. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2687 · Cited by 81
Trimethylaminuria Is Caused by Mutations of the FMO3 Gene in a North American Cohort
Akerman, B. R., Lemass, H., Chow, L. M. L., Lambert, D. M., Greenberg, C. R., Bibeau, C., Mamer, O., & Treacy, E. P. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2885 · Cited by 79
New metabolic pathways of alpha-lipoic acid.
Schupke, H., Hempel, R., Peter, G., Hermann, R., Wessel, K., Engel, J., & Kronbach, T. (2001) · PubMed · Cited by 78
N-oxygenation of clozapine by flavin-containing monooxygenase.
Tugnait, M., Hawes, E. M., McKay, G., Rettie, A. E., Haining, R. L., & Midha, K. K. (1997) · PubMed · Cited by 75
Biaglow, J. E., Issels, R. D., Gerweck, L. E., Varnes, M. E., Jacobson, B., Mitchell, J. B., & Russo, A. (1984) · Radiation Research · doi:10.2307/3576351 · Cited by 75
Population-Specific Polymorphisms of the Human FMO3 Gene: Significance for Detoxication
Cashman, J. R., Akerman, B. R., Forrest, S. M., & Treacy, E. P. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15124-0 · Cited by 75
Yamazaki, H., Fujieda, M., Togashi, M., Saito, T., Preti, G., Cashman, J. R., & Kamataki, T. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.022 · Cited by 73
Takamura, T., Sakurai, M., Ota, T., Ando, H., Kaneko, S., & Honda, M. (2004) · Diabetologia · doi:10.1007/s00125-004-1366-y · Cited by 73
In Vitro Evaluation of the Disposition of A Novel Cysteine Protease Inhibitor
Jacobsen, W., Christians, U., & Benet, L. Z. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15083-0 · Cited by 71
Lattard, V., Zhang, J., Tran, Q., Furnes, B., Schlenk, D., & Cashman, J. R. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.854 · Cited by 71
Kedderis, G. L., & Rickert, D. E. (1985) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07818-3 · Cited by 70
Lin, J., & Cashman, J. R. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970030o · Cited by 70
Cashman, J. R., Bi, Y., Lin, J., Youil, R., Knight, M. A., Forrest, S., & Treacy, E. P. (1997) · Chemical Research in Toxicology · doi:10.1021/tx9700533 · Cited by 70
Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans
Cashman, J. R., Park, S. B., Berkman, C. E., & Cashman, L. E. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03581-r · Cited by 70
Metabolism‐Dependent Toxicity of Methimazole in the Olfactory Nasal Mucosa
Brittebo, E. B. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00107.x · Cited by 69
CHUNG, W., KANG, J., PARK, C., Cho, M., & Cha, Y. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104617 · Cited by 67
Furnes, B., Feng, J., Sommer, S. S., & Schlenk, D. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.2.187 · Cited by 67
Cashman, J. R., & Ziegler, D. M. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10184-3 · Cited by 67
Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.
Cashman, J. R., Zhang, J., Leushner, J. R. A., & Braun, A. (2001) · PubMed · Cited by 66
Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.
Shehin, S. E., Williams, D. E., Larsen-Su, S. A., Stresser, D. M., & Hines, R. N. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24559-1 · Cited by 65
Self-citationDolphin, C. T., Janmohamed, A., Smith, R. L., Shephard, E. A., & Phillips, I. R. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00005 · Cited by 65
Kang, J., Chung, W., Lee, K., Park, C., Kang, J., Shin, I., Roh, H., Dong, M., Baek, H.-M., & Cha, Y. (2000) · Pharmacogenetics · doi:10.1097/00008571-200002000-00009 · Cited by 63
Cashman, J. R., Xiong, Y. N., Xu, L., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38081-4 · Cited by 62
Human Flavin-Containing Monooxygenase (form 3): Polymorphisms and Variations In Chemical Metabolism
Cashman, J. R. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.3.325 · Cited by 60
Size Limits of Thiocarbamides Accepted as Substrates by Human Flavin-Containing Monooxygenase 1
Kim, Y. M., & Ziegler, D. M. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15176-8 · Cited by 60
Rodriguez, R. J., & Buckholz, C. J. (2003) · Xenobiotica · doi:10.1080/0049825031000072243 · Cited by 60
In vitro-in vivo correlations of human (s)-nicotine metabolism
Berkman, C. E., Park, S. B., Wrighton, S. A., & Cashman, J. R. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00168-y · Cited by 57
Rodriguez, R. J., & Acosta, D. (1997) · PubMed · Cited by 57
Furnes, B. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh079 · Cited by 56
Rettie, A. E., Bogucki, B. D., Lim, I., et al. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11000-6 · Cited by 55
Rettie, A. E., Lawton, M. P., Sadeque, A. J. M., Meier, G. P., & Philpot, R. M. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1250 · Cited by 52
Rodriguez, R. J., Proteau, P., Márquez, B. L., Hetherington, C., Buckholz, C. J., & O’Connell, K. L. (1999) · PubMed · Cited by 52
Thiourea toxicity in mouse C3H/10T12 cells expressing human flavin-dependent monooxygenase 3
Smith, P. B., & Crespi, C. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00978-4 · Cited by 51
A hydrophobic sequence motif common to N-hydroxylating enzymes
Stehr, M., Diekmann, H., Smau, L., Seth, O., Ghisla, S., Singh, M., & Macheroux, P. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01166-3 · Cited by 51
Expression and Characterization of a Modified Flavin-containing Monooxygenase 4 from Humans
Itagaki, K., Carver, G. T., & Philpot, R. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20102 · Cited by 50
Williams, D. E., Shigenaga, M. K., & Castagnoli, N. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08534-4 · Cited by 48
Self-citationLanusse, C., Nare, B., & Prichard, R. K. (1993) · Xenobiotica · doi:10.3109/00498259309059382 · Cited by 48
Brunelle, A. N., Bi, Y., Lin, J., Russell, B. A., Luy, L., Berkman, C. E., & Cashman, J. R. (1997) · PubMed · Cited by 48
Chung, W., & Cha, Y.-N. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6866 · Cited by 47
Ripp, S. L., Itagaki, K., Philpot, R. M., & Elfarra, A. A. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1247 · Cited by 47
In Vivo Variability of TMA Oxidation Is Partially Mediated by Polymorphisms of the FMO3 Gene
Lambert, D. M., Mamer, O., Akerman, B. R., Choinière, L., Gaudet, D., Hamet, P., & Treacy, E. P. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3189 · Cited by 45
Sadeque, A. J. M., Thummel, K. E., & Rettie, A. E. (1993) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(93)90138-h · Cited by 45
Two novel mutations of theFMO3 gene in a proband with trimethylaminuria
Akerman, B. R., Forrest, S. M., Chow, L., Youil, R., Knight, M. A., & Treacy, E. P. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:5<376::aid-humu5>3.0.co;2-a · Cited by 45
Characterization of the purified microsomal FAD-containing monooxygenase from mouse and pig liver
Sabourin, P. J., & Hodgson, E. (1984) · Chemico-Biological Interactions · doi:10.1016/0009-2797(84)90025-5 · Cited by 43
Hines, R. N., Luo, Z., Hopp, K. A., Cabacungan, E., Koukouritaki, S. B., & McCarver, D. G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053686 · Cited by 43
Murphy, H. C., Dolphin, C. T., Janmohamed, A., HOLMES, H. C., Michelakakis, H., Shephard, E. A., CHALMERS, R. A., Phillips, I. R., & Iles, R. A. (2000) · Pharmacogenetics · doi:10.1097/00008571-200007000-00007 · Cited by 43
Mild trimethylaminuria caused by common variants in FMO3 gene
Zschocke, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02845-7 · Cited by 43
Potential role of the flavin-containing monooxygenases in the metabolism of endogenous compounds
Elfarra, A. A. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03582-s · Cited by 41
Genetic polymorphism of trimethylamine N-oxidation
Ayesh, R., & Smith, R. L. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90074-c · Cited by 41
Lin, J., & Cashman, J. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36940-x · Cited by 41
Chen, G. P., & Ziegler, D. M. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1346 · Cited by 40
Haining, R. L., Hunter, A. P., Sadeque, A. J. M., et al. (1997) · PubMed · Cited by 40
Flavin-containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes
Bhamre, S., Bhagwat, S. V., Shankar, S. K., Boyd, M. R., & Ravindranath, V. (1995) · Brain Research · doi:10.1016/0006-8993(94)01135-5 · Cited by 39
Trimethylamine and Fishy Taint in Eggs
Butler, E. J., & Fenwick, G. R. (1984) · World s Poultry Science Journal · doi:10.1079/wps19840005 · Cited by 39
Covalent binding of 14C- and 35S-labeled thiocarbamides in rat hepatic microsomes
Decker, C. J., & Doerge, D. R. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90256-i · Cited by 37
Yeast flavin-containing monooxygenase is induced by the unfolded protein response
Suh, J.-K., & Robertus, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.121 · Cited by 37
Khomenko, T., Deng, X., Sandor, Z., Tarnawski, A. S., & Szabó, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.017 · Cited by 36
Onderwater, R. C. A., Commandeur, J. N. M., Groot, E. J., Sitters, A., Menge, W. M. P. B., & Vermeulen, N. (1998) · Toxicology · doi:10.1016/s0300-483x(97)00169-8 · Cited by 34
Bhamre, S., Bhagwat, S. V., Shankar, S. K., Williams, D. E., & Ravindranath, V. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39557-1 · Cited by 33
Self-citationZiegler, D. M., Gräf, P., Poulsen, L. L., Sies, H., & Stahl, W. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00026a004 · Cited by 33
Onderwater, R. C. A., Commandeur, J. N. M., Menge, W. M. P. B., & Vermeulen, N. P. E. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980198p · Cited by 33
Krause, R. J., Glocke, S. C., & Elfarra, A. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.10.1137 · Cited by 32
Cs, P., Wg, C., Jh, K., Hk, R., Kh, L., & Cha, Y. N. (1999) · PubMed · Cited by 32
S-oxidation ofS-methyl-esonarimod by flavin-containing monooxygenases in human liver microsomes
Ohmi, N., Yoshida, H., Endo, H., Hasegawa, M., Akimoto, M., & Higuchi, S. (2003) · Xenobiotica · doi:10.1080/00498250310001624627 · Cited by 31
Redox Regulation of Yeast Flavin-Containing Monooxygenase
Suh, J.-K., Poulsen, L. L., Ziegler, D. M., & Robertus, J. D. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1965 · Cited by 31
Isoform Specificity of N-Deacetyl Ketoconazole by Human and Rabbit Flavin-Containing Monooxygenases
Rodriguez, R. J., & Miranda, C. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15190-2 · Cited by 30
Lin, J., Berkman, C. E., & Cashman, J. R. (1996) · Chemical Research in Toxicology · doi:10.1021/tx9600614 · Cited by 29
DIFFERENCES IN FMO2*1 ALLELIC FREQUENCY BETWEEN HISPANICS OF PUERTO RICAN AND MEXICAN DESCENT
Krueger, S. K., Siddens, L. K., Martin, S. R., Yu, Z., Pereira, C. B., Cabacungan, E., Hines, R. N., Ardlie, K., Raucy, J. L., & Williams, D. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001099 · Cited by 28
Self-citationPrimary aromatic amines: their N-oxidative bioactivation
Hlavica, P., Golly, I., Lehnerer, M., & Schulze, J. (1997) · Human & Experimental Toxicology · doi:10.1177/096032719701600805 · Cited by 27
Cerebral Metabolism of Imipramine and a Purified Flavin-Containing Monooxygenase from Human Brain
Bhagwat, S. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00175-d · Cited by 27
Metabolic oxygenation of organic nitrogen and sulfur compounds
Ziegler, D. M. (1984) · Cited by 26
Krueger, S. K., Siddens, L. K., Henderson, M. C., Andreasen, E. A., Tanguay, R. L., Pereira, C. B., Cabacungan, E., Hines, R. N., Ardlie, K., & Williams, D. E. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200504000-00008 · Cited by 25
Self-citationDetermination of FAD-Binding Domain in Flavin-Containing Monooxygenase 1 (FMO1)
Kubo, A., Itoh, S., Itoh, K., & Kamataki, T. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0242 · Cited by 24
Identification of Human Drug-Metabolizing Enzymes Involved in the Metabolism of SNI-2011.
Washio, T., Arisawa, H., Kohsaka, K., & Yasuda, H. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.1263 · Cited by 22
Discontinuous distribution of N-oxidation of dietary-derived trimethylamine in a British population
Zhang, A. Q., Mitchell, S. C., & Smith, R. L. (1996) · Xenobiotica · doi:10.3109/00498259609052497 · Cited by 22
Lattard, V., Longin‐Sauvageon, C., & Benoît, E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.253 · Cited by 20
Trimethylamine N-oxygenation and N-demethylation in rat liver microsomes
Gut, I., & Conney, A. H. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90409-p · Cited by 19
Blake, B. L., Philpot, R. M., Levi, P. E., & Hodgson, E. (1996) · Chemico-Biological Interactions · doi:10.1016/0009-2797(95)03679-2 · Cited by 18
Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 1
Stevens, J. C., Melton, R. J., Zaya, M. J., & Engel, L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.271 · Cited by 17
Cashman, J. R., Lattard, V., & Lin, J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.2.222 · Cited by 15
Cashman, J. R., Celestial, J. R., Leach, A. R., Newdoll, J., & Park, S. B. (1993) · Pharmaceutical Research · doi:10.1023/a:1018947714030 · Cited by 13
Effect of cysteamine hydrochloride on secretion of growth hormone in male swine
McElwain, K. V., Estienne, M. J., & Barb, C. R. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00183-6 · Cited by 13
The Assessment of Flavin-Containing Monooxygenase Activity in Intact Animals
Damani, L. A., & Nnane, I. P. (1996) · Drug metabolism and drug interactions · doi:10.1515/dmdi.1996.13.1.1 · Cited by 13
Deactivation of Sulindac‐Sulphide by Human Renal Microsomes
Eriksson, L. ‐., & Boström, H. (1988) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1988.tb01868.x · Cited by 12
Nnane, I. P., & Damani, L. A. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00290-x · Cited by 6
Cited by
Bennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070
Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme
Craciun, S., & Balskus, E. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215689109 · Cited by 701
Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes
Repka, L. M., Chekan, J. R., Nair, S. K., & van der Donk, W. A. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00591 · Cited by 547
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Hines, R. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.005 · Cited by 410
Fennema, D., Phillips, I. R., & Shephard, E. A. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070615 · Cited by 355
Metadata
- Authors
- Krueger, S. K., & Williams, D. E.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 106
- Issue
- 3
- Pages
- 357-387
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2018159164
- Cited by
- 567
- References
- 151
- FWCI
- 15.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.